Real-world efficacy of second-line therapies for Helicobacter pylori: a population-based study.

Bismuth quadruple therapy was the most effective second-line regimen for H. pylori in this real-world study. Despite a very low success rate, clarithromycin-containing triple therapies were still commonly used as second-line regimens.